Cargando…

Monoclonal gammopathy of clinical significance: in vivo demonstration of the anti-thrombotic effect of an acquired anti-thrombin antibody

Detalles Bibliográficos
Autores principales:	Schell, Berenice, Desconclois, Celine, Mariette, Xavier, Goujard, Cecile, Lenting, Peter J., Denis, Cecile V., Proulle, Valerie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776332/ https://www.ncbi.nlm.nih.gov/pubmed/32817284 http://dx.doi.org/10.3324/haematol.2019.242370

Ejemplares similares

Monoclonal Gammopathy of Thrombotic Significance
por: Gkalea, Vasiliki, et al.
Publicado: (2023)

Appropriate Anti-Thrombotic/Anti-Thrombin Therapy for Thrombotic Lesions
por: Iqbal, Zafar, et al.
Publicado: (2012)

Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report
por: Ventura, Sofia, et al.
Publicado: (2022)

Monoclonal gammopathies
por: Tozzi, S
Publicado: (2010)

Coexistence of Acquired Hemophilia and Antiphospholipid Serology in Monoclonal Gammopathy Patient
por: Belfeki, Nabil, et al.
Publicado: (2021)

Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy
por: Pascual-Goñi, Elba, et al.
Publicado: (2019)

Acquired von Willebrand Disease Associated with Monoclonal Gammopathy of Unknown Significance
por: Basnet, Sijan, et al.
Publicado: (2017)

Generalized Acquired Cutis Laxa Associated with Monoclonal Gammopathy of Dermatological Significance
por: Shalhout, Sophia Z., et al.
Publicado: (2020)

The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
por: Castillo, Jorge J., et al.
Publicado: (2021)

Monoclonal gammopathy of renal significance presenting with cryoglobulinaemia type I associated severe thrombotic microangiopathy
por: Hesius, Eva, et al.
Publicado: (2022)

Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity
por: Pepin, Marion, et al.
Publicado: (2016)

Author Correction: Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy
por: Pascual-Goñi, Elba, et al.
Publicado: (2021)

A thrombopoietin receptor agonist to rescue an unusual platelet transfusion-induced reaction in a p.V1316M-associated von Willebrand disease type 2B patient
por: Casari, Caterina, et al.
Publicado: (2022)

Thrombotic Microangiopathy, an Unusual Form of Monoclonal Gammopathy of Renal Significance: Report of 3 Cases and Literature Review
por: Filippone, Edward J., et al.
Publicado: (2021)

Monoclonal gammopathy of “ocular” significance
por: Karakus, Sezen, et al.
Publicado: (2019)

Cutaneous manifestations of monoclonal gammopathy
por: Claveau, Jean-Sebastien, et al.
Publicado: (2022)

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE
por: Bladé, J.
Publicado: (2023)

Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma
por: Wolfe, Zachary, et al.
Publicado: (2017)

Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic management
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2021)

Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy
por: Szalat, R, et al.
Publicado: (2014)

Acute Kidney Injury in Monoclonal Gammopathies
por: Menè, Paolo, et al.
Publicado: (2021)

Urticarial rash with leukocytosis and monoclonal gammopathy
por: De, Devea R., et al.
Publicado: (2022)

Necrobiotic Xanthogranuloma as Sign of Monoclonal Gammopathy
por: Conforti, Claudio, et al.
Publicado: (2022)

Evidence for immunoglobulin-mediated vasculitis caused by monoclonal gammopathy in monoclonal gammopathy of unclear significance prompting oncologic treatment
por: Drerup, Christian, et al.
Publicado: (2019)

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
por: Leung, Nelson, et al.
Publicado: (2018)

Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021)

Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy
por: Green, Allen, et al.
Publicado: (2022)

Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor
por: Wohner, Nikolett, et al.
Publicado: (2018)

Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008)

Prevalence of monoclonal gammopathy in HIV patients in 2014
por: Genet, Philippe, et al.
Publicado: (2014)

Monoclonal gammopathy of renal significance: case report
por: Fonseca, Gabriela Spacek da, et al.
Publicado: (2018)

Monoclonal Gammopathy of Undetermined Significance-associated Scleromyxoedema
por: Baxi, Kalgi D., et al.
Publicado: (2019)

Monoclonal gammopathy of renal significance: Diagnostic workup
por: Correia, Sofia O, et al.
Publicado: (2017)

“Acute” monoclonal gammopathy in severe COVID-19
por: Vazzana, Natale, et al.
Publicado: (2020)

Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
por: Moreno, David F., et al.
Publicado: (2021)

Diagnosis and management of monoclonal gammopathy of clinical significance
por: Cho, Hyungwoo
Publicado: (2022)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
por: Aslam, Nabeel, et al.
Publicado: (2021)

Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
por: Girard, Louis-Pierre, et al.
Publicado: (2022)

Monoclonal gammopathy of increasing significance: time to screen?
por: Chen, Lucia Y., et al.
Publicado: (2022)

Prevalence of MGCS Among Patients With Monoclonal Gammopathies
por: Theodorakakou, Foteini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lkl37g6j5ehijhm4npkgchc1it